Robert J. Riley

The evolution of strategies to minimise the risk of human drug-induced liver injury (DILI) in drug discovery and development

R. Riley, Paul A. Walker, Stephanie Ryder, 2020, Archives of Toxicology.

Discovery of potent and selective adamantane-based small-molecule P2X(7) receptor antagonists/interleukin-1beta inhibitors.

Martin Braddock, Mark Furber, Keith Bowers, 2007, Journal of medicinal chemistry.

Use of Hepatocytes to Assess the Contribution of Hepatic Uptake to Clearance in Vivo

Ken Grime, R. Riley, Robert J. Riley, 2007, Drug Metabolism and Disposition.

Preclinical Development Handbook: ADME and Biopharmaceutical Properties

Melvin E. Andersen, Harvey J. Clewell, Thierry Lavé, 2007 .

A UNIFIED MODEL FOR PREDICTING HUMAN HEPATIC, METABOLIC CLEARANCE FROM IN VITRO INTRINSIC CLEARANCE DATA IN HEPATOCYTES AND MICROSOMES

R. Austin, R. Riley, Robert J. Riley, 2005, Drug Metabolism and Disposition.